Filing Flows › ENvue Medical (FEED) › R&D spending
ENvue Medical (FEED) R&D spending by quarter
ENvue Medical's R&D spending was $510K in Q2 2026 (second quarter 2026), +9% from Q1 2026. Over the last 6 quarters it ranged from $39K (Q4 2025) to $530K (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $510K | +9% | — |
| Q1 2026 | $468K | 12× | -12% |
| Q4 2025 | $39K | -82% | -89% |
| Q3 2025 | $221K | -58% | — |
| Q1 2025 | $530K | +51% | — |
| Q4 2024 | $352K | — | — |
Q2 2026 at a glance
ENvue Medical, Q2 2026: revenue $239K (-52% year over year), net loss $4.9M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is ENvue Medical's R&D spending?
ENvue Medical's R&D spending was $510K in Q2 2026 (second quarter 2026), +9% from Q1 2026.
How has ENvue Medical's R&D spending changed?
Over the last 6 quarters it ranged from $39K (Q4 2025) to $530K (Q1 2025).